Literature DB >> 22927321

Comparing competing risk outcomes within principal strata, with application to studies of mother-to-child transmission of HIV.

Dustin M Long1, Michael G Hudgens.   

Abstract

In randomized trials to prevent breast milk transmission of human immunodeficiency virus (HIV) from mother to infant, investigators are often interested in assessing the effect of a treatment or intervention on the cumulative risk of HIV infection by time (age) t in infants who are alive and uninfected at a certain time point τ(0)  < t. Such comparisons are challenging for two reasons. First, infants are typically randomized at birth (time 0 < τ(0) ) such that comparisons between trial arms among the subset of infants alive and uninfected at τ(0) are subject to selection bias. Second, in most mother-to-child transmission (MTCT) trials competing risks are often present, such as death or cessation of breastfeeding prior to HIV infection. In this paper, we present methods for assessing the causal effect of a treatment on competing risk outcomes within principal strata. In MTCT trials, the causal effect of interest is that of treatment on the risk of HIV infection by time t > τ(0) within the principal stratum of infants who would be alive and uninfected by τ(0) regardless of randomization assignment. We develop large sample nonparametric bounds and a semiparametric sensitivity analysis model for drawing inference about this causal effect. We present a simulation study demonstrating that the proposed methods perform well in finite samples. We apply the proposed methods to a large, recent MTCT trial.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22927321      PMCID: PMC3494821          DOI: 10.1002/sim.5583

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  21 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  An estimator for treatment comparisons among survivors in randomized trials.

Authors:  Douglas Hayden; Donna K Pauler; David Schoenfeld
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

3.  On estimation of vaccine efficacy using validation samples with selection bias.

Authors:  Daniel O Scharfstein; M Elizabeth Halloran; Haitao Chu; Michael J Daniels
Journal:  Biostatistics       Date:  2006-03-23       Impact factor: 5.899

4.  CURRENT STATUS DATA WITH COMPETING RISKS: LIMITING DISTRIBUTION OF THE MLE.

Authors:  Piet Groeneboom; Marloes H Maathuis; Jon A Wellner
Journal:  Ann Stat       Date:  2008-01-01       Impact factor: 4.028

5.  Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology.

Authors:  A Alioum; F Dabis; L Dequae-Merchadou; G Haverkamp; M Hudgens; J Hughes; J Karon; V Leroy; M L Newell; B Richardson; G J Weverling
Journal:  Stat Med       Date:  2001-12-15       Impact factor: 2.373

6.  Sensitivity analyses comparing time-to-event outcomes only existing in a subset selected postrandomization and relaxing monotonicity.

Authors:  Bryan E Shepherd; Peter B Gilbert; Charles T Dupont
Journal:  Biometrics       Date:  2010-11-29       Impact factor: 2.571

7.  Causal Inference Under Multiple Versions of Treatment.

Authors:  Tyler J VanderWeele; Miguel A Hernán
Journal:  J Causal Inference       Date:  2013-05-01

8.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Authors:  Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

9.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

10.  Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

Authors:  Abubaker Bedri; Berhanu Gudetta; Abdulhamid Isehak; Solomon Kumbi; Sileshi Lulseged; Yohannes Mengistu; Arvind V Bhore; Ramesh Bhosale; Venkat Varadhrajan; Nikhil Gupte; Jayagowri Sastry; Nishi Suryavanshi; Srikanth Tripathy; Francis Mmiro; Michael Mubiru; Carolyne Onyango; Adrian Taylor; Philippa Musoke; Clemensia Nakabiito; Aida Abashawl; Rahel Adamu; Gretchen Antelman; Robert C Bollinger; Patricia Bright; Mohammad A Chaudhary; Jacqueline Coberly; Laura Guay; Mary Glenn Fowler; Amita Gupta; Elham Hassen; J Brooks Jackson; Lawrence H Moulton; Uma Nayak; Saad B Omer; Lidia Propper; Malathi Ram; Vivian Rexroad; Andrea J Ruff; Anita Shankar; Sheryl Zwerski
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

View more
  3 in total

1.  Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial.

Authors:  Peter B Gilbert; Bryan S Blette; Bryan E Shepherd; Michael G Hudgens
Journal:  J Causal Inference       Date:  2020-07-25

2.  Are all biases missing data problems?

Authors:  Chanelle J Howe; Lauren E Cain; Joseph W Hogan
Journal:  Curr Epidemiol Rep       Date:  2015-07-12

3.  Sharpening bounds on principal effects with covariates.

Authors:  Dustin M Long; Michael G Hudgens
Journal:  Biometrics       Date:  2013-11-18       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.